Understanding barriers and facilitators to implementing physical activity interventions for patients receiving immune checkpoint inhibitor therapy: A qualitative study Nov 1, 2023 - Jul 31, 2025
Immune checkpoint inhibitors (ICIs) have huge potential for the treatment of metastatic melanoma, renal, head and neck, and lung cancers. While recent research shows that exercise improves chemoradiotherapy outcomes, its role as an adjunctive treatme...
Read More about Understanding barriers and facilitators to implementing physical activity interventions for patients receiving immune checkpoint inhibitor therapy: A qualitative study.
Professor Michael Lind's Projects (7)
PreclinHUPET2: Enabling Enhanced Preclinical Nuclear Imaging For The North Of England Feb 1, 2023 - Jan 31, 2024
The grant application is to upgrade the preclinical scanning facilities for nuclear imaging of small animals (mice and rats) at the University of Hull. These facilities are used for research into disease and human health. The main areas that will be...
Read More about PreclinHUPET2: Enabling Enhanced Preclinical Nuclear Imaging For The North Of England.
A phase II, randomised feasibility trial of a tailored, home-based exercise programme on disease-free survival among early stage high-risk recurring cancers in Yorkshire Sep 1, 2022 - Aug 31, 2026
To determine the effect exercise has on preventing secondary cancers and improving 5-year survival rates among people diagnosed with breast, bowel, lung, or prostate cancers in Yorkshire.
Adapting a smartphone-based rehabilitation programme for older adults living with and beyond cancer: an intervention development study Apr 1, 2022 - Apr 30, 2024
The number of people living with and beyond cancer is growing; many are over 65 years old who often have different and more complicated healthcare needs than younger people.
Being active is one of the best things people with, or who have had, canc...
Read More about Adapting a smartphone-based rehabilitation programme for older adults living with and beyond cancer: an intervention development study.
TRANSFORM: YCR Cancercare: Experiences of diagnostic pathways and cancer care during the COVID-19 pandemic Apr 1, 2021 - Oct 31, 2024
The global coronavirus (COVID-19) outbreak has led to the disruption of cancer care services, as healthcare resources (personnel, facilities) were reprioritised to respond to the pandemic. The implications of this for cancer outcomes and patients’ ps...
Read More about TRANSFORM: YCR Cancercare: Experiences of diagnostic pathways and cancer care during the COVID-19 pandemic.
TRANSFORM: Reducing Inequalities in Cancer Outcomes in Yorkshire: Realising our potential for innovation in Diagnosis, Patient Management, Survivorship and Palliative Care Research Sep 1, 2017 - Dec 31, 2026
The death rate is higher in Yorkshire than the rest of England resulting in about 200 extra deaths each year of which more than half are in Hull. There are other significant cancer outcome inequalities between different groups; for example poorer pe...
Read More about TRANSFORM: Reducing Inequalities in Cancer Outcomes in Yorkshire: Realising our potential for innovation in Diagnosis, Patient Management, Survivorship and Palliative Care Research.